Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance
oleh: Marie Villares, Nelly Lourenço, Jeremy Berthelet, Suzanne Lamotte, Leslie Regad, Souhila Medjkane, Eric Prina, Fernando Rodrigues-Lima, Gerald F. Späth, Jonathan B. Weitzman
| Format: | Article |
|---|---|
| Diterbitkan: | Nature Portfolio 2022-11-01 |
Deskripsi
A microscopy-based screen of Medicines for Malaria Venture Pathogen Box identifies Trifloxystrobin as an effective alternative to Buparvaquone treatment for Theileria parasites infection, by inhibiting parasite survival and differentiation.